Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 4
41
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Association between IL2 Genotypes and Risk and Severity of Chronic Periodontitis in a Chinese Han Population: A Case-control Study

&
 

ABSTRACT

Chronic periodontitis (CP) is a kind of multifactorial common oral diseases. Multiple immune molecules including interleukin-2 (IL-2) are involved in the occurrence and development of CP. To investigate the association between the IL2 rs2069762 polymorphism and the risk of CP in Chinese individuals, we recruited 375 CP patients and 443 controls in this case-control study. The PCR-RFLP method was used for genotyping. Data revealed that the GG genotype was related with a decreased risk of CP (GG vs TT: OR, 0.58, 95%CI, 0.37–0.92, P-value = 0.020; GG vs TG+TT: OR, 0.61, 95%CI, 0.39–0.94, P-value = 0.027). Besides, G allele was shown to decrease the risk of CP. In addition, the IL2 rs2069762 polymorphism was related with the severity of CP. To sum up, the IL2 rs2069762 polymorphism is related with a decreased risk and severity of CP in Chinese individuals.

Disclosure statement

The authors declare that they have no conflicting interest.

Data availability statement

The data supporting the findings of this study are available within the article. No new datasets were generated during this study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.